<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03925311</url>
  </required_header>
  <id_info>
    <org_study_id>2014.637</org_study_id>
    <nct_id>NCT03925311</nct_id>
  </id_info>
  <brief_title>Transcriptome Profiling and Endometrial Receptivity</brief_title>
  <official_title>Transcriptome Profiling and Immune/ Biochemical Markers of Peripheral Blood to Predict Endometrial Receptivity and Successful Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to correlate and identify the biochemical markers which may reflect
      WOI. Blood samples will be collected and endometrial biopsy will be performed at particular
      time points.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endometrial receptivity in the midluteal phase of the menstrual cycle, known as the window of
      implantation (WOI), occurs only for a very short period of time. However, so far, there is no
      reliable clinical and biochemical indicators of WOI. Therefore, this study is to correlate
      and identify the biochemical markers which may reflect WOI.

      participants will be asked to be:

        1. performed endometrial biopsy

        2. taken blood for a few time points (e.g. pre-conception and being pregnant) to compare
           different kinds of biochemical markers.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 20, 2015</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The change of the transcriptome profiling in the peripheral blood</measure>
    <time_frame>From the day of endometrial biopsy through study completion, an average of 2 months</time_frame>
    <description>RNA per sample will be prepared into two portions. One is for RNA sequencing and the other is for small RNA sequencing. The next step is hydrolysis of RNA into 200-300 nucleotides prior to reverse transcription. When sequencing RNA other than mRNA the library preparation is modified. The cellular RNA is selected based on the desired size range. For miRNA, the RNA is isolated through size selection. Once isolated, linkers are added to the 3' and 5' end then purified. The final step is cDNA generation through reverse transcription.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of the immune markers in the peripheral blood</measure>
    <time_frame>From the day of endometrial biopsy through study completion, an average of 2 months</time_frame>
    <description>Immune markers including cytokines such as leukemia inhibitory factor, macrophage colony stimulating factor, interleukin - 1 beta, transforming growth factor beta-1, Tim-3, galectin-9 and other markers considered to play a role in implantation will also be measured.</description>
  </primary_outcome>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Pregnancy Related</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endometrial biopsy and blood sampling</intervention_name>
    <description>patient will be performed endometrial biopsy and collected blood samples at particular time points</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be recruited from the Prince of Wales Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age 20-40 years.

        Exclusion Criteria:

          -  Uncorrected uterine anomalies, such as septate or bicornuate uterus, fibroids
             (submucous/intramural).

          -  Intrauterine adhesions.

          -  Adenomyosis.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>This study only focuses on female group</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Tin Chiu :Li, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wing Ching Cheung, PhD</last_name>
    <phone>85235051764</phone>
    <email>cosycheung@cuhk.edu.hk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tin Chiu Li, MD, PhD</last_name>
    <phone>85235051764</phone>
    <email>tinchiu.li@cuhk.edu.hk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chinese University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wing Ching Cheung, PhD</last_name>
      <phone>(852)35051764</phone>
      <email>cosycheung@cuhk.edu.hk</email>
    </contact>
    <contact_backup>
      <last_name>Tin Chiu Li, MD, PhD</last_name>
      <phone>(852)35052800</phone>
      <email>tinchiu.li@cuhk.edu.hk</email>
    </contact_backup>
    <investigator>
      <last_name>Chi Chiu Wang, MBBS, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jin Huang, MBBS, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xiaoyan Chen, MBBS, MPhil, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 3, 2019</study_first_submitted>
  <study_first_submitted_qc>April 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2019</study_first_posted>
  <last_update_submitted>April 23, 2020</last_update_submitted>
  <last_update_submitted_qc>April 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Li Tin Chiu</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Transcriptome</keyword>
  <keyword>endometrial receptivity</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

